Logos Global Management LP Acquires 8.9% Stake in iBio, Inc.

2025-12-19SEC Filing SCHEDULE 13G (0000935836-25-000726)

Logos Global Management LP, along with affiliated entities Logos Global Management GP LLC, Logos Global Master Fund LP, Logos GP LLC, and Arsani William, has reported acquiring beneficial ownership of 2,000,000 shares of iBio, Inc. common stock. This represents an 8.9% ownership stake in the company, based on 22,487,308 shares outstanding as of September 30, 2025. The filing, dated December 19, 2025, indicates that the shares were acquired in the ordinary course of business and not with the intent to influence control of the issuer. Logos Global Management LP acts as the investment adviser, and Arsani William is identified as a control person of the reporting entities. The entities have entered into a joint filing agreement to facilitate compliance with SEC regulations.

Ticker mentioned:IBIOInstitution mentioned:Logos Global Management LP
Related industry:Biotechnology